Jens Christian Jensenius
Fundador en Helion Biotech ApS .
Relaciones activas
| Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
|---|---|---|---|---|
| Per Bo Pedersen Fischer | M | - |
Helion Biotech ApS
 Helion Biotech ApS Pharmaceuticals: MajorHealth Technology Helion Biotech ApS develops and manufactures drugs. It develops a recombinant human protein from the innate immune system (MASP-2) for therapeutic use in cancer. The firm's MASP-2 protein is used to prevent or treat infectious episodes in MASP-2 deficient patients undergoing chemotherapy. The company was founded by Jeppe Vesti Christensen, Per Bo Pedersen Fischer, Jens Christian Jensenius and Steffen Thiel in 2008 and is headquartered in Lyngby, Denmark. | 16 años |
| Jesper Zeuthen | M | - |
University of Aarhus
| - |
| Claus Vastrup | M | 82 |
University of Aarhus
| - |
| Lars Henrik Fugger | M | 64 |
University of Aarhus
| 28 años |
| Michael Christiansen | M | 79 |
University of Aarhus
| - |
| Finn Skou Pedersen | M | - |
University of Aarhus
| - |
| Mogens Ryttergård Duch | M | - |
University of Aarhus
| - |
| Karl Møller Bek | M | - |
University of Aarhus
| - |
| Sara Fevre Kindberg | M | - |
University of Aarhus
| - |
| Karl Anker Jørgensen | M | 69 |
University of Aarhus
| - |
| Caroline Søeborg Ahlefeldt-Laurvig-Bille | F | - |
University of Aarhus
| 5 años |
| Børge Obel | M | 76 |
University of Aarhus
| 20 años |
| Jon Steen Petersen | M | 77 |
University of Aarhus
| - |
| Jeppe Vesti Christensen | M | - |
Helion Biotech ApS
Helion Biotech ApS Pharmaceuticals: MajorHealth Technology Helion Biotech ApS develops and manufactures drugs. It develops a recombinant human protein from the innate immune system (MASP-2) for therapeutic use in cancer. The firm's MASP-2 protein is used to prevent or treat infectious episodes in MASP-2 deficient patients undergoing chemotherapy. The company was founded by Jeppe Vesti Christensen, Per Bo Pedersen Fischer, Jens Christian Jensenius and Steffen Thiel in 2008 and is headquartered in Lyngby, Denmark. | 16 años |
| Steffen Thiel | M | 63 |
Helion Biotech ApS
Helion Biotech ApS Pharmaceuticals: MajorHealth Technology Helion Biotech ApS develops and manufactures drugs. It develops a recombinant human protein from the innate immune system (MASP-2) for therapeutic use in cancer. The firm's MASP-2 protein is used to prevent or treat infectious episodes in MASP-2 deficient patients undergoing chemotherapy. The company was founded by Jeppe Vesti Christensen, Per Bo Pedersen Fischer, Jens Christian Jensenius and Steffen Thiel in 2008 and is headquartered in Lyngby, Denmark. | 16 años |
| Anders Nykjaer | M | - |
University of Aarhus
| - |
| Henrik Kagenow | M | - |
University of Aarhus
| - |
| Peder Tuborgh | M | 61 |
University of Aarhus
| - |
| Brian Bech Nielsen | M | 66 |
University of Aarhus
| 36 años |
| Carsten Bjerg | M | 64 |
University of Aarhus
| - |
| Nina Smith | F | 68 |
University of Aarhus
| - |
| Connie Hedegaard Koksbang | F | 63 |
University of Aarhus
| 7 años |
Gráfico relacional
Relaciones con varias empresas
Antiguas relaciones
| Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
|---|---|---|---|---|
| Ole Bitsch-Jensen | M | - |
Helion Biotech ApS
Helion Biotech ApS Pharmaceuticals: MajorHealth Technology Helion Biotech ApS develops and manufactures drugs. It develops a recombinant human protein from the innate immune system (MASP-2) for therapeutic use in cancer. The firm's MASP-2 protein is used to prevent or treat infectious episodes in MASP-2 deficient patients undergoing chemotherapy. The company was founded by Jeppe Vesti Christensen, Per Bo Pedersen Fischer, Jens Christian Jensenius and Steffen Thiel in 2008 and is headquartered in Lyngby, Denmark. | 2 años |
Estadísticas
| País | Relaciones | % del total |
|---|---|---|
| Dinamarca | 23 | 100.00% |
Antigüedad de la relación
Activas
Pasados
Hombre
Mujer
Administradores
Ejecutivos
Origen de las relaciones
- Bolsa de valores
- Insiders
- Jens Christian Jensenius
- Red Personal
